We are live on ! Find out more
AGP

Artia Global Partners Portfolio holdings

AUM $499M
1-Year Est. Return 186.05%
This Fund
S&P 500
This Quarter Est. Return
+0.61%
1 Year Est. Return
+186.05%
3 Year Est. Return
+672.09%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$499M
AUM Growth
-$206M
Cap. Flow
-$166M
Cap. Flow %
-33.16%
Top 10 Hldgs %
71.5%
Holding
65
New
10
Increased
6
Reduced
11
Closed
15

Top Buys

Rank Stock Value
1
ALMS
Alumis Inc
ALMS
+$8.13M
2
MRK icon
Merck
MRK
+$5.39M
3
JNJ icon
Johnson & Johnson
JNJ
+$5.26M
4
TERN
Terns Pharmaceuticals
TERN
+$4.3M
5
BIIB icon
Biogen
BIIB
+$3.4M

Top Sells

Rank Stock Value
1
ARGX icon
argenx
ARGX
+$27.4M
2
UGL icon
ProShares Ultra Gold
UGL
+$24.5M
3
QURE icon
uniQure
QURE
+$24.5M
4
SLNO
Soleno Therapeutics
SLNO
+$18.2M
5
VKTX icon
Viking Therapeutics
VKTX
+$17.3M

Sector Composition

Rank Sector Weight
1 Healthcare 88.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABVX
51
CALL
Abivax
ABVX
$11B
– –
-9,900
Closed -$1.34M
ALNY icon
52
Alnylam Pharmaceuticals
ALNY
$36.3B
– –
-17,400
Closed -$6.92M
CDTX
53
DELISTED
Cidara Therapeutics
CDTX
– –
-70,824
Closed -$15.6M
LYRA
54
DELISTED
LYRA THERAPEUTICS INC
LYRA
– –
-8,756
Closed -$27K
OCUL icon
55
CALL
Ocular Therapeutix
OCUL
$1.86B
– –
-85,200
Closed -$1.03M
OCUL icon
56
Ocular Therapeutix
OCUL
$1.86B
– –
-141,061
Closed -$1.71M
QURE icon
57
uniQure
QURE
$2.68B
– –
-1,023,539
Closed -$24.5M
RNAM
58
DELISTED
Avidity Biosciences
RNAM
– –
-60,100
Closed -$4.34M
SLNO
59
CALL
DELISTED
Soleno Therapeutics
SLNO
– –
-50,000
Closed -$2.31M
UGL icon
60
ProShares Ultra Gold
UGL
$650M
– –
-442,119
Closed -$24.5M
UGL icon
61
PUT
ProShares Ultra Gold
UGL
$650M
– –
-100,000
Closed -$5.55M
VTYX
62
DELISTED
Ventyx Biosciences
VTYX
– –
-695,982
Closed -$6.28M
ANRO icon
63
Alto Neuroscience
ANRO
$1.04B
– –
-29,192
Closed -$520K
UPB
64
Upstream Bio Inc
UPB
$349M
– –
-68,653
Closed -$1.86M
PVLA
65
Palvella Therapeutics
PVLA
$1.98B
– –
-59,200
Closed -$6.2M
1 2
3

Similar funds

MIP
Marietta Investment Partners Milwaukee, Wisconsin $499M AUM 41.06% 1-Year Est. Return
H2CM
H/2 Credit Manager Stamford, Connecticut $500M AUM 24.68% 1-Year Est. Return
HCI
Harraden Circle Investments New York $499M AUM 24.03% 1-Year Est. Return
KCL
KR Capital LP New York City, New York $499M AUM
PPC
Park Place Capital Homewood, Alabama $499M AUM 14.38% 1-Year Est. Return
HIC
Holderness Investments Company Greensboro, North Carolina $498M AUM 34.39% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
HSG
Helen Stephens Group Fort Worth, Texas $501M AUM 16.23% 1-Year Est. Return

Artia Global Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Artia Global Partners held 65 positions worth $499M, down 29% from $706M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Artia Global Partners withdrew a net $166M in Q1 2026, closing 15 positions and reducing 11 holdings. Its most notable exit was ProShares Ultra Gold, an estimated $24.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 85% a quarter earlier.

Against the trend, Artia Global Partners opened a new position in Alumis Inc worth $7.16M.

  • Artia Global Partners's largest Q1 2026 buy was Alumis Inc: 325,046 shares worth $7.16M.
  • Artia Global Partners added most to Revolution Medicines in Q1 2026, an estimated $2.1M increase.
  • Artia Global Partners's biggest Q1 2026 reduction was argenx, cutting an estimated $27.4M.
  • Artia Global Partners fully exited ProShares Ultra Gold in Q1 2026, selling an estimated $24.5M.
  • Artia Global Partners's ten largest holdings make up 72% of its $499M portfolio in Q1 2026.
  • Artia Global Partners opened 10 new positions and closed 15 in Q1 2026.
  • Artia Global Partners's portfolio value fell 29% quarter-over-quarter to $499M.

Based on Artia Global Partners's 13F filing for Q1 2026, filed 15 May 2026.